Recent Finacing
Recent Raise
Evaxion Biotech develops AI-driven immuno-informatics platforms (including RAVEN) to design T- and B-cell-targeted immunotherapies and vaccines, integrating structural prediction with DNA delivery and manufacturing; advancing personalized peptide clinical programs.